Home › Calculator › REMI Dividend Calculator 2026
REMI Dividend Calculator 2026
No dividendHealthcareRemedent, Inc. · OTC
Price: $0.00 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
REMI is not a dividend-focused stock
REMI pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
REMI Dividend Yield
Remedent, Inc. (REMI) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When REMI pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Remedent, Inc. (REMI) — Dividend Analysis 2026
Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent supplies GlamSmile veneers, which are exceptionally thin shells bonded to the front surfaces of a patient's teeth. Beyond physical products, the company offers a suite of digital tools and services aimed at enhancing dental practice operations. These include the SmileMe Mirror, an integrated marketing concept that enables quick smile consultations in about ten minutes; SmileSketch, simulation software capable of creating visual previews of potential aesthetic results; and various "Treatment Pages" designed to explain the advantages of specific dental procedures. Furthermore, Remedent provides the Condor, an advanced intra-oral 3D scanning device. The company's expertise also extends to dental implant technologies and related treatment methodologies. Remedent distributes its products to dental professionals in nearly 30 countries, spanning regions such as Asia, Europe, the Middle East, Canada, and the United States, utilizing both its internal sales team and third-party distributors. Founded in 1986, the company's corporate headquarters are located in Ghent, Belgium.
REMI Dividend & DRIP — Frequently Asked Questions
Does REMI pay a dividend?
No. Remedent, Inc. (REMI) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of REMI?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does REMI have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. REMI has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to REMI
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full REMI DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open REMI position with:
🌍 REMI Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold REMI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 REMI Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 REMI Dividend Payment Schedule
REMI pays quarterly — 4 times per year. Ex-div: —.
📊 REMI vs Healthcare Benchmarks
How REMI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for REMI sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ REMI Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2015-12-02 | 399,819 | $0.15 | $60.0K | ||
| Buy | 2015-12-02 | 399,819 | $0.40 | $159.9K | ||
| Sale | 2013-07-24 | 2,848,408 | $0.09 | $242.4K | ||
| Sale | 2013-07-18 | 225,000 | $0.10 | $22.6K | ||
| Sale | 2013-07-19 | 165,000 | $0.10 | $16.5K | ||
| Sale | 2013-07-19 | 500 | $0.11 | $55.00 | ||
| Sale | 2013-07-16 | 713,025 | $0.09 | $67.5K | ||
| Sale | 2012-11-30 | 45,000 | $0.12 | $5.4K | ||
| Sale | 2012-12-03 | 200,000 | $0.12 | $24.0K | ||
| Sale | 2012-11-28 | 60,000 | $0.13 | $8.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare REMI with peers: REMI vs CYPS · REMI vs DGEN · REMI vs EMGE
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where REMI earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the REMI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Remedent, Inc. (REMI) is currently trading at $0.00, trading near its 52-week high. It does not currently pay a regular dividend.
Does REMI Pay a Dividend? Remedent, Inc. Dividend Status
Remedent, Inc. (REMI) is a healthcare stock trading at $0.00. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest REMI News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your REMI DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.